TransMedics to Present at the Canaccord Genuity 45th Annual Growth Conference

ANDOVER, Mass., July 29, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will present at the upcoming Canaccord Genuity 45^th Annual Growth Conference at the InterContinental Boston Hotel. Management is scheduled to present on Tuesday, August 12, 2025, at 11:30 a.m. Eastern Standard Time.

Read more at prnewswire.com